Promising Gene Therapy Trials Suspended Over Potential Cancer Risk
![](https://i.kinja-img.com/gawker-media/image/upload/s--__m7yVOj--/c_fit,fl_progressive,q_80,w_636/ennxitrnrpikmxtabzdl.jpg)
On Tuesday, Biotech company Bluebird suspended its trials of gene therapy as a treatment for blood-related disorders over concerns of a possible increased risk of cancer. The company cited the recent discovery of two patients given the experimental treatment who developed a form of blood cancer, along with a similar…